Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
<h4>Background</h4>The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict rel...
Guardado en:
Autores principales: | Tiago Nunes, Maria Josefina Etchevers, Maria Jose Sandi, Susana Pinó Donnay, Teddy Grandjean, Maria Pellisé, Julián Panés, Elena Ricart, Juan Lucio Iovanna, Jean-Charles Dagorn, Mathias Chamaillard, Miquel Sans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0389dc42bc54270b8afa3f8f79ed991 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021) -
Seminars in inflammatory bowel disease
Publicado: (2001) - Inflammatory Bowel Disease Monitor
-
MSC therapy for inflammatory bowel disease
por: Mikhail A. Konoplyannikov, et al.
Publicado: (2021) -
Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
por: Laila Aldars-García, et al.
Publicado: (2021)